Kiyotaka Kawai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kiyotaka Kawai has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Junichiro Mitsui
Department of Comprehensive Reproductive Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8519, Japan
5 shared publications - Kuniaki Ota
Department of Obstetrics and Gynecology Kawasaki Medical School Okayama Japan
5 shared publications - Makiko Tajima
Department of Reproductive Medicine, Kameda IVF Clinic Makuhari, Chiba 261-8501, Japan
4 shared publications - Tomonori Ishikawa
Department of Perinatal and Maternal Medicine (Ibaraki), Institute of Science Tokyo, Bunkyo-ku, Japan
3 shared publications - Yurie Nako
Department of Reproductive Medicine, Kameda IVF Clinic Makuhari, Chiba 261-8501, Japan
3 shared publications - Atsushi Fukui
Department of Obstetrics and Gynecology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan
2 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Successful pregnancy following extensive myomectomy for diffuse uterine leiomyomatosis
Diffuse uterine leiomyomatosis (DUL) is a rare condition characterized by innumerable leiomyomas (fibroids) diffusely replacing the myometrium, often leadi
- 13 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessSuccessful pregnancy following extensive myomectomy for diffuse uterine leiomyomatosis
Diffuse uterine leiomyomatosis (DUL) is a rare condition characterized by innumerable leiomyomas (fibroids) diffusely replacing the myometrium, often leadi
- Open Access
- 9 June 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1595970
Comprehensive mathematical modeling of age-dependent oocyte quality and quantity for predicting live birth rate
Background: Age-related decline in fertility is widely recognized. However, a quantitative evaluation of changes in oocyte quality and quantity remains insufficient. Therefore, developing a mathematical model to quantitatively predict live birth rates affected by these changes is essential for supporting decision-making in assisted reproductive technology.Methods: In this retrospective cohort study, we developed a mathematical model to predict live birth rates based on oocyte quality and quantity using IVF treatment data from our clinic over an 8-year period. In the first stage, medically meaningful model functions were selected, and curve fitting was performed using weighted nonlinear least-squares regression to quantify age-related changes in oocyte quality and quantity. For oocyte quality, a comparative analysis was conducted on our clinical data and other large-scale datasets, modeling the live birth rate per single vitrified-warmed blastocyst transfer (SVBT) in correlation with the euploidy rate. For oocyte quantity, the distributions of anti-Müllerian hormone levels, antral follicle count, mature oocyte count, and transferable embryo count were analyzed by two-dimensional weighted nonlinear least-squares regression. In the second stage, logistic regression was applied to analyze live birth rates per SVBT and oocyte pick-up, incorporating multiple explanatory variables.Results: The adjusted R-squared values for the curve fitting results were above 0.9, indicating high fitting accuracy. In oocyte quality evaluation, all datasets showed that the values declined to half their peak by the age of 40 years. With respect to oocyte quantity, complete distribution characteristics were successfully modeled, enabling calculations at any percentile value. Logistic regression analysis incorporating blastocyst grade and culture duration as explanatory variables allowed for embryo selection based on a single indicator (i.e., the live birth rate). In the predictive model for live birth rate per oocyte pick-up, which included age, AMH levels, and number of retrieval cycles as explanatory variables, logistic regression analysis showed an AUC of 0.84 and an accuracy of 76.4%, demonstrating high predictive performance.Conclusion: Mathematical models of age-dependent oocyte quality and quantity were successfully developed. These models were integrated to construct a multi-variable predictive tool for estimating live birth rates, offering valuable insights for reproductive decision-making.
- 9 June 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1595970
Open AccessComprehensive mathematical modeling of age-dependent oocyte quality and quantity for predicting live birth rate
Background: Age-related decline in fertility is widely recognized. However, a quantitative evaluation of changes in oocyte quality and quantity remains insufficient. Therefore, developing a mathematical model to quantitatively predict live birth rates affected by these changes is essential for supporting decision-making in assisted reproductive technology.Methods: In this retrospective cohort study, we developed a mathematical model to predict live birth rates based on oocyte quality and quantity using IVF treatment data from our clinic over an 8-year period. In the first stage, medically meaningful model functions were selected, and curve fitting was performed using weighted nonlinear least-squares regression to quantify age-related changes in oocyte quality and quantity. For oocyte quality, a comparative analysis was conducted on our clinical data and other large-scale datasets, modeling the live birth rate per single vitrified-warmed blastocyst transfer (SVBT) in correlation with the euploidy rate. For oocyte quantity, the distributions of anti-Müllerian hormone levels, antral follicle count, mature oocyte count, and transferable embryo count were analyzed by two-dimensional weighted nonlinear least-squares regression. In the second stage, logistic regression was applied to analyze live birth rates per SVBT and oocyte pick-up, incorporating multiple explanatory variables.Results: The adjusted R-squared values for the curve fitting results were above 0.9, indicating high fitting accuracy. In oocyte quality evaluation, all datasets showed that the values declined to half their peak by the age of 40 years. With respect to oocyte quantity, complete distribution characteristics were successfully modeled, enabling calculations at any percentile value. Logistic regression analysis incorporating blastocyst grade and culture duration as explanatory variables allowed for embryo selection based on a single indicator (i.e., the live birth rate). In the predictive model for live birth rate per oocyte pick-up, which included age, AMH levels, and number of retrieval cycles as explanatory variables, logistic regression analysis showed an AUC of 0.84 and an accuracy of 76.4%, demonstrating high predictive performance.Conclusion: Mathematical models of age-dependent oocyte quality and quantity were successfully developed. These models were integrated to construct a multi-variable predictive tool for estimating live birth rates, offering valuable insights for reproductive decision-making.
- Open Access
- 1 January 2025
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 24 (1) , e12662
A Comparative Study of Intravenous Immunoglobulin and Lipid Emulsion in Patients With Reproductive Failures Associated With NK Cell Abnormalities
Purpose: To compare the effects of intravenous immunoglobulin (IVIG) and lipid emulsion (LE) therapies on reproductive failure such as recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) associated with natural killer (NK) cell abnormalities. Methods: NK cell abnormalities were defined as peripheral blood NK (pNK) cell activity of 40% or higher and CD16 + /CD56 dim uterine NK (uNK) cells at 18% or higher. IVIG and LE were administered to RPL and RIF patients. In patients undergoing IVF‐ET, treatment was initiated either before ET, on ET day, or after ET. Results: Implantation rates of 48.3% and 47.8% were revealed in the IVIG and LE groups, respectively, with no significant difference. For patients with RPL, live birth rates were 75.0% for the IVIG group and 72.5% for the LE group, with no significant difference. For timings of administration before ET, on ET day, or after ET, the clinical pregnancy rates were 47.6%, 0%, and 0%, respectively, in the IVIG group and 30.0%, 12.5%, and 0%, respectively, in the LE group. Higher clinical pregnancy rates were observed when each treatment was initiated before ET. Conclusions: Both treatments exhibited comparable therapeutic effects on reproductive disorders associated with NK cell abnormalities.
- 1 January 2025
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 24 (1) , e12662
Open AccessA Comparative Study of Intravenous Immunoglobulin and Lipid Emulsion in Patients With Reproductive Failures Associated With NK Cell Abnormalities
Purpose: To compare the effects of intravenous immunoglobulin (IVIG) and lipid emulsion (LE) therapies on reproductive failure such as recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) associated with natural killer (NK) cell abnormalities. Methods: NK cell abnormalities were defined as peripheral blood NK (pNK) cell activity of 40% or higher and CD16 + /CD56 dim uterine NK (uNK) cells at 18% or higher. IVIG and LE were administered to RPL and RIF patients. In patients undergoing IVF‐ET, treatment was initiated either before ET, on ET day, or after ET. Results: Implantation rates of 48.3% and 47.8% were revealed in the IVIG and LE groups, respectively, with no significant difference. For patients with RPL, live birth rates were 75.0% for the IVIG group and 72.5% for the LE group, with no significant difference. For timings of administration before ET, on ET day, or after ET, the clinical pregnancy rates were 47.6%, 0%, and 0%, respectively, in the IVIG group and 30.0%, 12.5%, and 0%, respectively, in the LE group. Higher clinical pregnancy rates were observed when each treatment was initiated before ET. Conclusions: Both treatments exhibited comparable therapeutic effects on reproductive disorders associated with NK cell abnormalities.
- Open Access
- 31 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 179
A Large Study About Reproductive Factors That Predict Hysterosalpingography-Identified Tubal Pathology: An Insight into the Necessity of Preconception Screening
Background/Objectives: Hysterosalpingography (HSG) is pivotal in delineating tubal pathology, but is associated with pain and exposure to ionizing radiation. This study investigated which reproductive factors predict HSG-identified tubal pathology. Methods: From May 2016 to August 2023, 3322 infertile females with HSG (mean age 33.9 ± 4.3 years) were assessed for fallopian tube status. Results: HSG indicated that 2764 had patent tubes while 558 (16.8%) had non-patent tubes. Unilateral and bilateral absence of free contrast spillage occurred in 377 (11.3%) and 181 (5.4%) cases, respectively. Non-spillage, denoted as non-patency, was seen in 148 (4.5%) and 153 (4.6%) right and left cases, respectively. Tubal occlusion was observed in 181 (5.4%) and 159 (5.4%) right and left cases, respectively. Hydrosalpinx was found in 37 (1.2%) right and 58 (1.7%) left cases. Multivariate logistic regression revealed CT-IgG positivity (odds ratio [OR]: 1.57), endometrioma (OR: 1.64), and fibroids (OR: 1.58) as independent factors for increased non-patency. CT-IgG positivity (OR: 1.92) and fibroids (OR: 1.88) were significant risk factors for occlusion. Painful defecation (OR: 2.79), CT-IgA positivity (OR: 2.09), CT-IgG positivity (OR: 2.07), and endometrioma (OR: 3.11) were significant risk factors for hydrosalpinx. Conclusions: In females with painful defecation, CT-IgG positivity, endometrioma, and fibroids, HSG may be used as a second-line investigation, with laparoscopy as the preferred assessment tool.
- 31 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 179
Open AccessA Large Study About Reproductive Factors That Predict Hysterosalpingography-Identified Tubal Pathology: An Insight into the Necessity of Preconception Screening
Background/Objectives: Hysterosalpingography (HSG) is pivotal in delineating tubal pathology, but is associated with pain and exposure to ionizing radiation. This study investigated which reproductive factors predict HSG-identified tubal pathology. Methods: From May 2016 to August 2023, 3322 infertile females with HSG (mean age 33.9 ± 4.3 years) were assessed for fallopian tube status. Results: HSG indicated that 2764 had patent tubes while 558 (16.8%) had non-patent tubes. Unilateral and bilateral absence of free contrast spillage occurred in 377 (11.3%) and 181 (5.4%) cases, respectively. Non-spillage, denoted as non-patency, was seen in 148 (4.5%) and 153 (4.6%) right and left cases, respectively. Tubal occlusion was observed in 181 (5.4%) and 159 (5.4%) right and left cases, respectively. Hydrosalpinx was found in 37 (1.2%) right and 58 (1.7%) left cases. Multivariate logistic regression revealed CT-IgG positivity (odds ratio [OR]: 1.57), endometrioma (OR: 1.64), and fibroids (OR: 1.58) as independent factors for increased non-patency. CT-IgG positivity (OR: 1.92) and fibroids (OR: 1.88) were significant risk factors for occlusion. Painful defecation (OR: 2.79), CT-IgA positivity (OR: 2.09), CT-IgG positivity (OR: 2.07), and endometrioma (OR: 3.11) were significant risk factors for hydrosalpinx. Conclusions: In females with painful defecation, CT-IgG positivity, endometrioma, and fibroids, HSG may be used as a second-line investigation, with laparoscopy as the preferred assessment tool.
- Open Access
Seasonal Serum 25(OH) Vitamin D Level and Reproductive or Immune Markers in Reproductive-Aged Women with Infertility: A Cross-Sectional Observational Study in East Japan
Several studies have reported that vitamin D may modify human reproductive functions; however, the results are conflicting. We aimed to comprehensively evaluate serum vitamin D levels and examine the relationship between serum vitamin D levels and ovarian reserve markers, and immune markers of implantation, in reproductive-aged Japanese women with infertility.in reproductive-aged women with infertility. This cross-sectional, single-center study included reproductive-aged women who underwent preconception screening for fertility. Serum vitamin D levels and reproductive and immune markers were measured. Standard and advanced statistical techniques were used. We observed a statistically significant difference in the seasonal and monthly 25(OH) vitamin D levels; the 25(OH) vitamin D level during winter was the lowest among all seasons. However, there was no linear correlation between 25(OH) vitamin D levels and ovarian reserve markers, such as follicle-stimulating hormone and anti-Müllerian hormone, or the Th1/Th2 cell ratio, which is used as an implantation-related immunological marker. In this large-scale study, we evaluated the serum 25(OH) vitamin D concentration in reproductive-aged women with infertility in Japan; however, there was no association between reproductive function and vitamin D levels.
Open AccessSeasonal Serum 25(OH) Vitamin D Level and Reproductive or Immune Markers in Reproductive-Aged Women with Infertility: A Cross-Sectional Observational Study in East Japan
Several studies have reported that vitamin D may modify human reproductive functions; however, the results are conflicting. We aimed to comprehensively evaluate serum vitamin D levels and examine the relationship between serum vitamin D levels and ovarian reserve markers, and immune markers of implantation, in reproductive-aged Japanese women with infertility.in reproductive-aged women with infertility. This cross-sectional, single-center study included reproductive-aged women who underwent preconception screening for fertility. Serum vitamin D levels and reproductive and immune markers were measured. Standard and advanced statistical techniques were used. We observed a statistically significant difference in the seasonal and monthly 25(OH) vitamin D levels; the 25(OH) vitamin D level during winter was the lowest among all seasons. However, there was no linear correlation between 25(OH) vitamin D levels and ovarian reserve markers, such as follicle-stimulating hormone and anti-Müllerian hormone, or the Th1/Th2 cell ratio, which is used as an implantation-related immunological marker. In this large-scale study, we evaluated the serum 25(OH) vitamin D concentration in reproductive-aged women with infertility in Japan; however, there was no association between reproductive function and vitamin D levels.
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e39-e40
THE INFERTILE FEMALE WITH A HISTORY OF RECURRENT IMPLANTATION FAILURE AND RECURRENT MISCARRIAGE HAS LACKED DYNAMIC CHANGES AND NETWORK WITH IMMUNE MARKERS DURING THE MENSTRUAL CYCLE
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e39-e40
THE INFERTILE FEMALE WITH A HISTORY OF RECURRENT IMPLANTATION FAILURE AND RECURRENT MISCARRIAGE HAS LACKED DYNAMIC CHANGES AND NETWORK WITH IMMUNE MARKERS DURING THE MENSTRUAL CYCLE
Oncofertility‐related psycho‐educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial
BackgroundA couples' psycho-educational program called Oncofertility! Psycho-Education and Couple Enrichment (O!PEACE) therapy was created and its effect when provided before cancer treatment was examined. MethodsThis multicenter randomized controlled trial with nonmasking, parallel two-group comparison enrolled women aged 20 to 39 years with early-stage breast cancer and their partners. They were randomly assigned to receive O!PEACE (37 couples) or usual care (37 couples). Primary end points were cancer-related posttraumatic stress symptoms, symptoms of depression, and anxiety. Secondary end points were stress-coping strategies, resilience, and marital relationship. ResultsWomen receiving psycho-educational therapy had significantly reduced Impact of Event Scale-revised version for Japanese scores (p = .011, eta(2)(p) = = .089). For patients with Impact of Event Scale-revised version for Japanese scores at baseline >= 18.27, O!PEACE therapy improved these scores when compared with usual care (U = 172.80, p = .027, r = 0.258). A >5-point reduction was present in 59.3% and 30% of women in the O!PEACE therapy and usual-care groups, respectively. For partners, O!PEACE therapy significantly improved stress-coping strategies (95% CI, -0.60 to -0.05; p = .018, eta(2)(p) = = .074) and escape-avoidance marital communication (95% CI, -0.33 to -0.08; p = .001, eta(2)(p) = .136). O!PEACE therapy significantly improved the partners' support (95% CI, 0.10-0.50; p = .001, eta(2)(p) = .127), the rate of receiving fertility preservation consultations, and knowledge levels. ConclusionsO!PEACE therapy before cancer treatment can improve posttraumatic stress symptoms, stress-coping behavior, and marital relationships. Larger sample sizes and longer term follow-up are required. Plain Language Summary A psycho-educational program, the Oncofertility! Psycho-Education and Couple Enrichment (O!PEACE) therapy program was developed and evaluated for women diagnosed with breast cancer and their partners.A multicenter randomized controlled trial showed that the O!PEACE psycho-educational therapy, with only two precancer treatment sessions, can reduce cancer-related posttraumatic stress symptoms and improve oncofertility knowledge and marital relationships in young adult patients with breast cancer.The therapy could also improve stress-coping strategies in marital communications with their partners. Couples may use O!PEACE psycho-educational therapy to consider fertility preservation and improve their psychosocial aspects.
Oncofertility‐related psycho‐educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial
BackgroundA couples' psycho-educational program called Oncofertility! Psycho-Education and Couple Enrichment (O!PEACE) therapy was created and its effect when provided before cancer treatment was examined. MethodsThis multicenter randomized controlled trial with nonmasking, parallel two-group comparison enrolled women aged 20 to 39 years with early-stage breast cancer and their partners. They were randomly assigned to receive O!PEACE (37 couples) or usual care (37 couples). Primary end points were cancer-related posttraumatic stress symptoms, symptoms of depression, and anxiety. Secondary end points were stress-coping strategies, resilience, and marital relationship. ResultsWomen receiving psycho-educational therapy had significantly reduced Impact of Event Scale-revised version for Japanese scores (p = .011, eta(2)(p) = = .089). For patients with Impact of Event Scale-revised version for Japanese scores at baseline >= 18.27, O!PEACE therapy improved these scores when compared with usual care (U = 172.80, p = .027, r = 0.258). A >5-point reduction was present in 59.3% and 30% of women in the O!PEACE therapy and usual-care groups, respectively. For partners, O!PEACE therapy significantly improved stress-coping strategies (95% CI, -0.60 to -0.05; p = .018, eta(2)(p) = = .074) and escape-avoidance marital communication (95% CI, -0.33 to -0.08; p = .001, eta(2)(p) = .136). O!PEACE therapy significantly improved the partners' support (95% CI, 0.10-0.50; p = .001, eta(2)(p) = .127), the rate of receiving fertility preservation consultations, and knowledge levels. ConclusionsO!PEACE therapy before cancer treatment can improve posttraumatic stress symptoms, stress-coping behavior, and marital relationships. Larger sample sizes and longer term follow-up are required. Plain Language Summary A psycho-educational program, the Oncofertility! Psycho-Education and Couple Enrichment (O!PEACE) therapy program was developed and evaluated for women diagnosed with breast cancer and their partners.A multicenter randomized controlled trial showed that the O!PEACE psycho-educational therapy, with only two precancer treatment sessions, can reduce cancer-related posttraumatic stress symptoms and improve oncofertility knowledge and marital relationships in young adult patients with breast cancer.The therapy could also improve stress-coping strategies in marital communications with their partners. Couples may use O!PEACE psycho-educational therapy to consider fertility preservation and improve their psychosocial aspects.
- Open Access
- 4 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1250
Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review
About 60% of cases of recurrent pregnancy loss have unexplained etiology. Immunotherapy for unexplained recurrent pregnancy loss is still unestablished. A 36-year-old woman, not obese, had a stillbirth at 22 gestational weeks and a spontaneous abortion at 8 weeks. She had been examined for recurrent pregnancy loss at previous clinics with no significant findings. When she visited our clinic, a hematologic test showed a Th1/Th2 ratio imbalance. Ultrasonography, hysteroscopy, and semen analysis showed no abnormalities. She successfully conceived by embryo transfer in hormone replacement therapy cycle. However, she had a miscarriage at 19 weeks. The baby had no deformities, but a chromosomal test was not performed, according to the parents’ will. The placenta pathologically suggested hemoperfusion problems. Her and her husband’s chromosomal tests showed normal karyotypes. Other examinations revealed a repeated Th1/Th2 ratio imbalance and a high resistance index of uterine radial artery blood flow. She was administered low-dose aspirin, intravenous immunoglobulin, and unfractionated heparin after the second embryo was transferred. Her baby was healthily born by cesarean section at 40 weeks. Intravenous immunoglobulin therapy can be a choice for recurrent miscarriage without risk factors because it has clinically beneficial influences on the patient’s immunological aberration.
- 4 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1250
Open AccessSuccessful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review
About 60% of cases of recurrent pregnancy loss have unexplained etiology. Immunotherapy for unexplained recurrent pregnancy loss is still unestablished. A 36-year-old woman, not obese, had a stillbirth at 22 gestational weeks and a spontaneous abortion at 8 weeks. She had been examined for recurrent pregnancy loss at previous clinics with no significant findings. When she visited our clinic, a hematologic test showed a Th1/Th2 ratio imbalance. Ultrasonography, hysteroscopy, and semen analysis showed no abnormalities. She successfully conceived by embryo transfer in hormone replacement therapy cycle. However, she had a miscarriage at 19 weeks. The baby had no deformities, but a chromosomal test was not performed, according to the parents’ will. The placenta pathologically suggested hemoperfusion problems. Her and her husband’s chromosomal tests showed normal karyotypes. Other examinations revealed a repeated Th1/Th2 ratio imbalance and a high resistance index of uterine radial artery blood flow. She was administered low-dose aspirin, intravenous immunoglobulin, and unfractionated heparin after the second embryo was transferred. Her baby was healthily born by cesarean section at 40 weeks. Intravenous immunoglobulin therapy can be a choice for recurrent miscarriage without risk factors because it has clinically beneficial influences on the patient’s immunological aberration.
- Open Access
- 12 December 2022
- Published by MDPI AG in Endocrines
- Vol. 3 (4) , 821-830
Effects of Hydrosalpinx on Endometrial Receptivity and Uterine Microbiome: An Interesting Case of Double Uterus with Unilateral Hydrosalpinx
Endometrial receptivity array (ERA)—an objective tool used in assisted reproductive technology—is used for personalized embryo transfer in in vitro fertilization. Hydrosalpinx affects implantation through various mechanisms. However, its effects on ERA are not well established. In this case report, we present the diagnosis and treatment of a 34-year-old nulligravida woman with infertility for two years, obesity, double uterus with unilateral hydrosalpinx and right kidney deficiency. Based on ERA results, endometrial microbiome metagenomic analysis (EMMA), analysis of infectious chronic endometritis (ALICE), and CD138 immunostaining, the patient was treated with hormonal replacement cycle and amoxicillin/clavulanic acid. After one week of amoxicillin/clavulanic acid administration, the vitirified-warmed 4AA blastocyst was transferred to the left uterus—which was absent of hydrosalpinx and easily accessible to transfer and pregnancy was achieved. To the best of our knowledge, this case study is the first one in which we found that there were no differences between the left and right uterus in ERA, EMMA, ALICE, and CD138 immunostainings. Hence, we suggest that hydrosalpinx does not necessarily cause endometrial changes in all cases. Further research to evaluate the effects of hydrosalpinx on implantation with ERA and EMMA/ALICE is warranted.
- 12 December 2022
- Published by MDPI AG in Endocrines
- Vol. 3 (4) , 821-830
Open AccessEffects of Hydrosalpinx on Endometrial Receptivity and Uterine Microbiome: An Interesting Case of Double Uterus with Unilateral Hydrosalpinx
Endometrial receptivity array (ERA)—an objective tool used in assisted reproductive technology—is used for personalized embryo transfer in in vitro fertilization. Hydrosalpinx affects implantation through various mechanisms. However, its effects on ERA are not well established. In this case report, we present the diagnosis and treatment of a 34-year-old nulligravida woman with infertility for two years, obesity, double uterus with unilateral hydrosalpinx and right kidney deficiency. Based on ERA results, endometrial microbiome metagenomic analysis (EMMA), analysis of infectious chronic endometritis (ALICE), and CD138 immunostaining, the patient was treated with hormonal replacement cycle and amoxicillin/clavulanic acid. After one week of amoxicillin/clavulanic acid administration, the vitirified-warmed 4AA blastocyst was transferred to the left uterus—which was absent of hydrosalpinx and easily accessible to transfer and pregnancy was achieved. To the best of our knowledge, this case study is the first one in which we found that there were no differences between the left and right uterus in ERA, EMMA, ALICE, and CD138 immunostainings. Hence, we suggest that hydrosalpinx does not necessarily cause endometrial changes in all cases. Further research to evaluate the effects of hydrosalpinx on implantation with ERA and EMMA/ALICE is warranted.
- 10 March 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (5) , 1061-1075
A practical survey of fertility‐preservation treatments in the startup phase in Japan
Aim: The actual status of fertility preservation treatments in the startup phase in Japan was investigated as a basis for discussing future directions.Methods: This study was conducted as “Research project to promote support of children and parenting 2016” which was supported by Ministry of Health in Japan with the approval of the institutional review board at St. Marianna University. Subjects of the survey were facilities registered with the Japan Society of Obstetrics and Gynecology as fertility preservation facilities, and facilities belonging to the Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories. We provided questionnaires to survey both the medical care system and cases for which fertility preservation was implemented between 2006 and 2016.Results: Responses were obtained from 68 facilities (of the 64, 59 [92.2%] responded to the questionnaire and 9 clinics cooperated). Many facilities limited the cryopreservation of oocytes and ovaries to patients 40–41 years old and the use of eggs to patients 44–45 years old. In the patient survey, 812 cases of oocyte cryopreservation and 201 cases of ovarian tissue cryopreservation were performed during study period. Breast cancer was the most indicated disease, with oocyte cryopreservation in the late 30s and ovarian tissue cryopreservation in the early 30s. Very few babies were born from fertility preservation, and no live birth cases of ovarian tissue cryopreservation were identified.Conclusions: Even from the early days, fertility preservation was implemented according to certain standards in Japan, but was characterized by a large variety of facilities.
- 10 March 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 48 (5) , 1061-1075
A practical survey of fertility‐preservation treatments in the startup phase in Japan
Aim: The actual status of fertility preservation treatments in the startup phase in Japan was investigated as a basis for discussing future directions.Methods: This study was conducted as “Research project to promote support of children and parenting 2016” which was supported by Ministry of Health in Japan with the approval of the institutional review board at St. Marianna University. Subjects of the survey were facilities registered with the Japan Society of Obstetrics and Gynecology as fertility preservation facilities, and facilities belonging to the Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories. We provided questionnaires to survey both the medical care system and cases for which fertility preservation was implemented between 2006 and 2016.Results: Responses were obtained from 68 facilities (of the 64, 59 [92.2%] responded to the questionnaire and 9 clinics cooperated). Many facilities limited the cryopreservation of oocytes and ovaries to patients 40–41 years old and the use of eggs to patients 44–45 years old. In the patient survey, 812 cases of oocyte cryopreservation and 201 cases of ovarian tissue cryopreservation were performed during study period. Breast cancer was the most indicated disease, with oocyte cryopreservation in the late 30s and ovarian tissue cryopreservation in the early 30s. Very few babies were born from fertility preservation, and no live birth cases of ovarian tissue cryopreservation were identified.Conclusions: Even from the early days, fertility preservation was implemented according to certain standards in Japan, but was characterized by a large variety of facilities.